Form: S-3

Registration statement under Securities Act of 1933

November 18, 2026

S-3 S-3 EX-FILING FEES 0000318306 ABEONA THERAPEUTICS INC. N/A N/A 0000318306 2026-11-18 2026-11-18 0000318306 1 2026-11-18 2026-11-18 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

ABEONA THERAPEUTICS INC.

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Common stock, par value $0.01 per share Other 12,494,426 $ 2.27 $ 28,362,347.02 0.000087 $ 2,467.52
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 28,362,347.02

$ 2,467.52

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 2,467.52

Offering Note

1

(1) Represents an aggregate of 12,494,426 shares of Abeona Therapeutics Inc.'s (the "Company") common stock, par value $0.01 per share ("Common Stock"), which consists of (i) 4,494,383 shares issued to Ellodi Pharmaceuticals, L.P., a Delaware limited partnership, in connection with the Company's acquisition of certain assets relating to APT-1011, (ii) 6,400,000 shares of Common Stock (the "Private Placement Shares") issued to the purchasers pursuant to the Securities Purchase Agreement dated November 6, 2026, by and among the Company and the purchasers signatory thereto (the "Securities Purchase Agreement"), and (iii) 1,600,043 shares of Common Stock issuable upon the exercise of outstanding pre-funded warrants to purchase shares of Common Stock (the "Pre-Funded Warrants") issued to the applicable Selling Stockholders in connection with the closing of the private placement (the "Pre-Funded Warrant Shares"). Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement also covers any additional number of shares of common stock as may be issuable as a result of stock splits, stock dividends, or similar transactions with respect to the shares of common stock being registered pursuant to this registration statement. (2) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) of the Securities Act, on the basis of the average of the high and low prices for a share of the Company's common stock as reported on the Nasdaq Capital Market on November 13, 2026, which date is a date within five business days prior to the filing of this registration statement.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims
Fee Offset Sources
Rule 457(p)
Fee Offset Claims
Fee Offset Sources
Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date